针对性系统疗法 针对性系统疗法 针对性系统疗法 针对性系统疗法 针对性系统疗法 针对性系统疗法 针对性系统疗法 针对性系统疗法 针对性系统疗法 针对性系统疗法 针对性系统疗法 针对性系统疗法 针对性系统疗法 针对性系统疗法
Richard W Kim1, Megan Lam2, Katrina Abuabara3,4
1University of California San Francisco School of Medicine, San Francisco, CA, USA.
American journal of clinical dermatology
|January 12, 2024
概括
适度至严重的亚托皮性皮炎的新疗法包括生物药物和Janus激酶 (JAK) 抑制剂. 共享决策是根据个体患者的需求和安全概况,在这些有效疗法之间做出选择的关键.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 中度至重度的亚托皮性皮炎 (AD) 治疗已经扩展到局部治疗之外.
- 生物药物和Janus激酶 (JAK) 抑制剂为耐火性AD提供了向的免疫调节方法.
- 临床试验表明这些新型药物的高疗效和可接受的安全性.
研究的目的:
- 帮助共同决策,为患有亚托皮炎的成年人选择全身疗法.
- 总结和比较生物制剂和口服JAK抑制剂的疗效,安全性和监测.
- 为患有亚托皮性皮肤炎的特殊人群提供治疗选择指南.
主要方法:
- 审查最近的临床试验数据和网络元分析.
- 对生物药物和JAK抑制剂的疗效和安全性概况进行比较分析.
- 考虑治疗因素,包括输送方式,成本和发病速度.
主要成果:
- 在网络元分析中,较高剂量的abrocitinib和upadacitinib比生物药物更有效.
- 在生物药物中,dupilumab似乎比tralokinumab和lebrikizumab更有效.
- 生物药物通常被认为比JAK抑制剂更安全,尽管对JAK抑制剂的担忧通常基于较旧的药物.
结论:
- 对阿托皮性皮炎的个性化治疗决定需要患者和医生之间的共同决策.
- 在生物药物和JAK抑制剂之间做出选择需要平衡疗效,安全性和患者特定因素.
- 提供了基于证据的建议,建议在患有亚托皮性皮肤炎的特殊人群中使用全身疗法.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
299
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
299
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
Antiasthma Drugs: Leukotriene Modifiers
302
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
302
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
139
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
139
Hypersensitivities
661
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
661


